Literature DB >> 2410626

Viral polypeptides detected by a complement-dependent neutralizing murine monoclonal antibody to human cytomegalovirus.

L Rasmussen, J Mullenax, R Nelson, T C Merigan.   

Abstract

Murine monoclonal antibodies were produced which coimmunoprecipitated, under reducing conditions, 130,000- and 55,000-dalton (Da) polypeptides from cells infected with human cytomegalovirus (CMV) strain AD169. A 92,000-Da species, possibly a biosynthetic intermediate, was also detectable. One of the monoclonal antibodies, 15D8, neutralized CMV AD169 only in the presence of guinea pig complement. A second monoclonal antibody, 14E10, coimmunoprecipitated the 130,000- and 55,000-Da polypeptides but did not neutralize viral infectivity. By sequential immunoprecipitation, both monoclonal antibodies have been shown to recognize the same polypeptides. Monoclonal antibody 15D8 detected the 130,000- and 55,000-Da polypeptides in five of six clinical strains and three laboratory strains tested. The 14E10 monoclonal antibody detected the 130,000-Da protein in four of six CMV clinical isolates and in strain AD169 but did not immunoprecipitate any polypeptides from extracts of cells infected with either Towne or Davis laboratory strains. In kinetic studies, the synthesis of the 130,000-Da polypeptide preceded the appearance of the 55,000-Da polypeptide. In infected cells radiolabeled with a pulse of L-[35S]methionine, the isotope was initially detected in the 130,000-Da polypeptide but could be chased into the 55,000-Da polypeptide. These polypeptides exist in the intracellular and extracellular virus as disulfide-linked multimers. Extracellular virus contained a high-molecular-weight (greater than 200,000 Da) multimer composed entirely of 55,000-Da polypeptides. In extracts from infected cells an additional high-molecular-weight multimer was detected consisting of disulfide-linked 130,000-Da polypeptides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410626      PMCID: PMC254930     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Persistence of the cytomegalovirus genome in human cells.

Authors:  E S Mocarski; M F Stinski
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Membrane proteins specified by herpes simplex viruses. IV. Conformation of the virion glycoprotein designated VP7(B2).

Authors:  M Sarmiento; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

3.  Analysis of antigenic diversity among human cytomegaloviruses by kinetic neutralization tests with high-titered rabbit antisera.

Authors:  J L Waner; T H Weller
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

4.  Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses.

Authors:  B J Graham; Y Minamishima; G R Dresman; H G Haines; M Benyesh-Melnick
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Shared antigenic determinants between two distinct classes of proteins in cells infected with herpes simplex virus.

Authors:  M Zweig; C J Heilman; H Rabin; B Hampar
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

6.  Structural and nonstructural proteins of strain Colburn cytomegalovirus.

Authors:  W Gibson
Journal:  Virology       Date:  1981-06       Impact factor: 3.616

7.  Characterization of anti-reovirus immunoglobulins secreted by cloned hybridoma cell lines.

Authors:  P W Lee; E C Hayes; W K Joklik
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

8.  Multimeric forms of herpes simplex virus type 2 glycoproteins.

Authors:  R Eberle; R J Courtney
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

9.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

Authors:  L Rasmussen; D Kelsall; R Nelson; W Carney; M Hirsch; D Winston; J Preiksaitis; T C Merigan
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226

10.  Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies.

Authors:  L Pereira; M Hoffman; M Tatsuno; D Dondero
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

View more
  32 in total

1.  Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.

Authors:  S Keay; T C Merigan; L Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Identification and characterization of three distinct families of glycoprotein complexes in the envelopes of human cytomegalovirus.

Authors:  D R Gretch; B Kari; L Rasmussen; R C Gehrz; M F Stinski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Human immune responses to major human cytomegalovirus glycoprotein complexes.

Authors:  Y N Liu; B Kari; R C Gehrz
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Immune responses to isolated human cytomegalovirus envelope proteins.

Authors:  E Gönczöl; F Hudecz; J Ianacone; B Dietzschold; S Starr; S A Plotkin
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases.

Authors:  D M Benko; W Gibson
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

6.  Molecular cloning and analysis of three cDNA clones homologous to human cytomegalovirus RNAs present during late infection.

Authors:  J Martinez; S C St Jeor
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Comparative sequence analysis of human cytomegalovirus strains.

Authors:  R Lehner; T Stamminger; M Mach
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

8.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.

Authors:  A D Yurochko; E S Hwang; L Rasmussen; S Keay; L Pereira; E S Huang
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.

Authors:  U Utz; W Britt; L Vugler; M Mach
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein.

Authors:  S W Chou; K M Scott
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.